Literature DB >> 18157656

Studies on the role of amino acid stereospecificity in amyloid beta aggregation.

Veer Bala Gupta1, S S Indi, K S J Rao.   

Abstract

Amyloid beta (Abeta) deposition and neurodegeneration are the two related events in the pathogenesis of Alzheimer's disease. Several factors modulate the conformation and physical properties of Abeta, which in turn affects its biological functions. Among these, age-dependent changes in the stereospecificity of the amino acids comprising Abeta is one such factors. In the present study, we investigated the aggregation property of Abeta as a function of the stereospecificity of amino acids comprising the peptide. We carried out our study by comparing the physical properties of Abeta(1-40) all-L and Abeta(1-40) all-D enantiomers using various biophysical techniques. These results indicated that the aggregation and folding parameters of Abeta are stereospecific and the aggregation property strongly depends upon the amino acid sequence and their stereospecificity. This may possibly help to understand the stereospecific role of amino acids comprising Abeta in its aggregation and its relevance to neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157656     DOI: 10.1007/s12031-007-0070-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  20 in total

1.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

Authors:  C J Barrow; M G Zagorski
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

2.  Racemization of individual aspartate residues in human myelin basic protein.

Authors:  R Shapira; K D Wilkinson; G Shapira
Journal:  J Neurochem       Date:  1988-02       Impact factor: 5.372

Review 3.  Gliotransmission at central glutamatergic synapses: D-serine on stage.

Authors:  Magalie Martineau; Gérard Baux; Jean-Pierre Mothet
Journal:  J Physiol Paris       Date:  2006-02-07

4.  Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations.

Authors:  W Garzon-Rodriguez; M Sepulveda-Becerra; S Milton; C G Glabe
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 5.  Isoaspartate formation and neurodegeneration in Alzheimer's disease.

Authors:  T Shimizu; A Watanabe; M Ogawara; H Mori; T Shirasawa
Journal:  Arch Biochem Biophys       Date:  2000-09-15       Impact factor: 4.013

6.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

7.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Authors:  D Burdick; B Soreghan; M Kwon; J Kosmoski; M Knauer; A Henschen; J Yates; C Cotman; C Glabe
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

8.  Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

Authors:  M F Knauer; B Soreghan; D Burdick; J Kosmoski; C G Glabe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease.

Authors:  Takekazu Kubo; Yoshihiro Kumagae; Carol A Miller; Isao Kaneko
Journal:  J Neuropathol Exp Neurol       Date:  2003-03       Impact factor: 3.685

10.  In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

Authors:  Takekazu Kubo; Satoko Nishimura; Yoshihiro Kumagae; Isao Kaneko
Journal:  J Neurosci Res       Date:  2002-11-01       Impact factor: 4.164

View more
  8 in total

1.  The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies.

Authors:  Lucia Buccarello; Alessandra Sclip; Matteo Sacchi; Anna Maria Castaldo; Ilaria Bertani; Andrea ReCecconi; Silvia Maestroni; Gianpaolo Zerbini; Paolo Nucci; Tiziana Borsello
Journal:  Oncotarget       Date:  2017-08-03

2.  Interactions of amyloid β peptide 1-40 and cerebrosterol.

Authors:  Zdena Krištofiková; Zdeněk Kříž; Daniela Rípová; Jaroslav Koča
Journal:  Neurochem Res       Date:  2011-11-17       Impact factor: 3.996

3.  Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53.

Authors:  Jack C C Liao; Robert Lam; Vaclav Brazda; Shili Duan; Mani Ravichandran; Justin Ma; Ting Xiao; Wolfram Tempel; Xiaobing Zuo; Yun-Xing Wang; Nickolay Y Chirgadze; Cheryl H Arrowsmith
Journal:  Structure       Date:  2011-03-09       Impact factor: 5.006

4.  Copper enhances amyloid-beta peptide neurotoxicity and non beta-aggregation: a series of experiments conducted upon copper-bound and copper-free amyloid-beta peptide.

Authors:  Xueling Dai; Yaxuan Sun; Zhaolan Gao; Zhaofeng Jiang
Journal:  J Mol Neurosci       Date:  2009-08-14       Impact factor: 3.444

5.  A study for the cause of ferulic acid-induced quenching of tyrosine fluorescence and whether it is a reliable marker of intermolecular interactions or not.

Authors:  Antonella Sgarbossa; Francesco Lenci
Journal:  J Fluoresc       Date:  2013-03-06       Impact factor: 2.217

6.  All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers.

Authors:  Ricardo Capone; Hyunbum Jang; Samuel A Kotler; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ruth Nussinov; Ratnesh Lal
Journal:  J Chem Theory Comput       Date:  2012-02-03       Impact factor: 6.006

7.  Neuroprotective effects of exogenous brain-derived neurotrophic factor on amyloid-beta 1-40-induced retinal degeneration.

Authors:  Mohd Aizuddin Mohd Lazaldin; Igor Iezhitsa; Renu Agarwal; Puneet Agarwal; Nafeeza Mohd Ismail
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

Review 8.  TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.

Authors:  Vivek K Gupta; Yuyi You; Veer Bala Gupta; Alexander Klistorner; Stuart L Graham
Journal:  Int J Mol Sci       Date:  2013-05-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.